-
公开(公告)号:US20160347845A1
公开(公告)日:2016-12-01
申请号:US15234581
申请日:2016-08-11
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
IPC: C07K16/28
CPC classification number: C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2319/30
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
Abstract translation: 本公开尤其提供了中和抗体及其与ActRIIB结合并用于其的部分。
-
公开(公告)号:US20250066488A1
公开(公告)日:2025-02-27
申请号:US18947795
申请日:2024-11-14
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US20220098309A1
公开(公告)日:2022-03-31
申请号:US17245526
申请日:2021-04-30
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US20190023797A1
公开(公告)日:2019-01-24
申请号:US16054446
申请日:2018-08-03
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US20180051088A1
公开(公告)日:2018-02-22
申请号:US15477204
申请日:2017-04-03
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
IPC: C07K16/28
CPC classification number: C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2319/30
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US09624301B2
公开(公告)日:2017-04-18
申请号:US15234581
申请日:2016-08-11
Applicant: Acceleron Pharma Inc. , Dyax Corp.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
IPC: C07K16/28
CPC classification number: C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2319/30
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US09403910B2
公开(公告)日:2016-08-02
申请号:US13828419
申请日:2013-03-14
Applicant: Acceleron Pharma, Inc.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
IPC: C07K16/28 , A61K31/711 , C07K16/40
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US20130189269A1
公开(公告)日:2013-07-25
申请号:US13828419
申请日:2013-03-14
Applicant: ACCELERON PHARMA, INC.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
IPC: C07K16/40
CPC classification number: C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2319/30
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
-
公开(公告)号:US20150030606A1
公开(公告)日:2015-01-29
申请号:US14508988
申请日:2014-10-07
Applicant: Acceleron Pharma, Inc.
Inventor: Ravindra Kumar , Asya Grinberg , Monique Davies , Diana Martik , Janja Cosic , Rachel Kent , David Buckler
CPC classification number: C07K16/2863 , C07K16/40 , C07K2317/21 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/76 , C07K2317/92 , C07K2319/30
Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
Abstract translation: 本公开尤其提供了中和抗体及其与ActRIIB结合并用于其的部分。
-
-
-
-
-
-
-
-